The appropriate use of whole blood, packed red cells (PRC), fresh-frozen plasma (FFP) and platelets was evaluated. The indications, effectiveness and complications of transfusion were determined on the basis of existing criteria described in the literature and prevailing practices in the hospital. A retrospective review of medical records demonstrated that the administration of PRC was unnecessary in 15% of the cases and that the use of FFP was not indicated hi 67% of the patients. The result of PRC transfusion was inadequate in 4% of the cases. Haemolysis and circulatory overload occurred hi 2% and 4% of the patients, respectively. Major hazards such as Acquired Immunodeficiency Syndrome (AIDS) and hepatitis were not observed. In order to improve the appropriate use of blood components, transfusion guidelines were proposed to all medical departments.
INTRODUCTION
The importance of quality assurance has increased over the last years and has become apparent in hospital management as well as in the interest of the policy-makers. The continuous savings in the health care sector during the past decade are one of the main reasons that justify this concern [1] . In the Academisch Ziekenhuis van de Vrije Universiteit Brussels (AZ-VUB)-a university hospital of 680 beds-a medical audit committee was established in 1991. The committee is charged with the promotion of quality assurance of medical care in the hospital and comprises five permanent members: a pathologist, a microbiologist, a urologist, a nephrologist and the medical director. Members of other disciplines can be called upon because of their expertise in specific domains.
Blood usage review is identified as one of six important medical staff quality assurance functions and is considered a top priority by the prominent American Joint Commission on Accreditation of Health Care Organizations [2, 3] . Hazards associated with transfusions including the transmission of diseases such as Acquired Immunodeficiency Syndrome (AIDS) and hepatitis should be minimized. Recent studies showed, however, that blood and blood components are often used in an inappropriate way [4] [5] [6] [7] [8] . The medical audit committee agreed that assessing the appropriateness of transfusion practice should be an integral part of the quality assurance program in every hospital and decided to initiate a study on this scope in the AZ-VUB.
MATERIALS AND METHODS
The method of medical audit was strictly applied. The different steps of the audit process 
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are shown in Figure 1 [9] . The purpose of the study was defined as follows: the evaluation of the appropriateness of the use of whole blood, packed red cells (PRC), fresh-frozen plasma (FFP) and platelets in the hospital. On the basis of a review of the literature and taking into account the prevailing medical practices in the hospital, criteria were established focusing on the indications of transfusion according to the product transfused and on the occurrence of complications. For the use of PRC, criteria were also defined in order to evaluate the effectiveness of transfusion [10] [11] [12] [13] [14] . Each criterium consists of an element and a standard of 0% or 100% (see Appendix). Transfusion experts from the Blood Transfusion Centre, from the Laboratory of Haematology and Haemostasis, and from the Medical Service of Haematology were closely involved in determining the evaluation criteria. Infants under 16 years were excluded from the study as the established criteria only apply to adults. A random sample of 65 transfusion requests received at the Transfusion Centre for adult inpatients over a 3-week period was taken. The medical records of these patients were retrospectively reviewed by an independent physician who was not involved in any decision-making regarding patient care. In the case of repeated transfusions during the same period of hospitalization only the first transfusion was included in the study. The medical record reviewing process consisted of searching for the elements of the preset criteria depending on the product transfused. Transfusion was considered appropriate if the element was present (standard 100%) or absent (standard 0%) in the medical record depending on the value of the attributed standard. Poorly documented medical records lacking essential data for the evaluation of transfusion were excluded. A total of 50 medical records were analysed. Table 1 shows the number of reviewed records per medical department and per speciality of the requesting physician. All transfusions considered inappropriate by the reviewer for one or more criteria were finally submitted to the medical audit committee and individually discussed together with an expert from the Transfusion Centre.
RESULTS
Forty-eight patients had a transfusion of PRC. Six of them also received FFP. PRC, FFP and platelets were simultaneously administered to one patient. Two patients received platelets only. Whole blood or FFP alone was never used. The percentages of inappropriate transfusions according to the predetermined criteria are shown in Table 2 .
Indications
The use of PRC was unnecessary in seven out of 48 patients. Four received only one unit of PRC. These seven patients all suffered from well-supported chronic anaemia or limited acute blood loss and had haemoglobin (Hgb) of more than 8 g/100 ml before transfusion.
Transfusion of platelets was always appropriate. The use of FFP was not indicated according to criterium No. 4 (see Appendix) in four out of six cases. Apparently, FFP is often used in cases of major intra-operative or gastrointestinal bleeding albeit coagulation tests (prothrombin time and activated partial thromboplastin time) are normal. The one patient receiving PRC, FFP and platelets at the same time suffered from an extreme hyper-acute blood loss because of a ruptured aneurysm of the aorta. As whole blood was not immediately available (see Appendix, criterium No. 2), the simultaneous transfusion of PRC, FFP and platelets was considered appropriate by the audit committee.
Effectiveness of PRC transfusion
Transfusion of PRC proved inadequate in at least two cases. One patient received only one unit of PRC, resulting in a Hgb level of less than 10 g/100 ml post-transfusion. In another patient Hgb was below 10 g/100 ml within 48 h before discharge. In one case the result of PRC transfusion could not be evaluated as the patient died within 24 h of transfusion.
Complications
None of the transfused patients presented an allergic or febrile reaction. Haemolysis occurred in one case. In two other cases a circulatory overload was observed as a result of an unnecessary or too rapidly administered transfusion. Finally no mention of hepatitis or human immunodeficiency virus seroconversion was found in the medical records within 6 months of the date of transfusion.
DISCUSSION
The analysis of the medical records turned out to be very troublesome and took up a lot of time. The essential data for evaluation were often difficult to find as the patient records were sometimes voluminous and often poorly organized. Finally, 23% of the reviewed records were excluded from the study as a result of missing vital information. Improving the quality of the medical record was recognized as a priority by the audit committee. A new audit, focusing on this topic, should be considered in the near future.
Although only a relatively small number of records, were analysed, this evaluation led to some interesting findings with regard to transfusion practices in the hospital. Despite the evident risks of transfusion, blood components are overused: transfusion of PRC was revealed as unnecessary in 15% of the cases and FFP transfusion was judged not indicated in 67% of cases. Comparisons with similar studies are difficult to make because of differences in local criteria. Variations in existing practices can partly be explained by the lack of a broad consensus with regard to the indications of the use of blood components.
The audit committee concluded that ongoing efforts should be made to increase the attention of the requesting physicians to the risks and benefits of transfusion, especially as the AZ-VUB is a university hospital and plays a major role in the training of medical students and residents. Unnecessary transfusions should be prevented by a higher awareness of the risks as well as by better decision-making with regard to the use of blood and blood components based on written guidelines. The appropriateness of transfusions should be assessed periodically.
In order to fulfil these recommendations the following actions were taken by the committee: the results of the transfusion audit were fed back to the heads of the medical departments and the established criteria were proposed as guidelines for the correct use of blood and blood components in the hospital. Moreover, a new audit of transfusion practices was announced within 6 to 12 months in order to assess the effectiveness of these actions.
In conclusion, the method of medical audit, although troublesome and time consuming, was revealed to be a successful means of evaluating medical practice in the hospital. Factors n, V, VH, EX, X, XI and XD -active bleeding or surgical procedure required in less than 6 h in patients treated with coumarin -on advice of haematologist Effectiveness of PRC-transfusion 5.
-Hgb a 10 g/100 ml post-transfusion -Hgb a 10 g/100 ml within 72 h before discharge Complications 6.
-allergic reactions (cutaneous rash; urticaria) 7.
-febrile reaction 8.
-haemolytic reaction (shock, oliguria, disseminated intra vascular coagulation) 9.
-circulatory overload 10.
-hepatitis within 6 months of transfusion 11.
-HIV seroconversion within 6 months of transfusion Hgb, haemoglobin; HTV, human immunodeficiency virus; PTT, prothrombin time; APTT, activated partial thromboplastin time.
•For criterium 1 (PRC) exceptions are: coronary disease, chronic lung disease, cerebral ischaemia, palliative treatment in terminal patients, preoperative status (indication: Hgb <10 g/100 ml).
